ANNX · Company research
Annexon, Inc. (ANNX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | Annexon, Inc. (Nasdaq: ANNX) announced the grant of equity inducement awards to six new non-executive employees, consisting of options to purchase 1,270,000 shares of common stock at an exercise price of $3.60 per share with a ten-year term and four-year vesting schedule. | View source ↗ | GlobeNewswire Inc. | Oct 16, 2026 | neutral | 0 | 1 |
| ANNX Forecast — Price Target — Prediction for 2027 - TradingView | ANNX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Oct 15, 2026 | neutral | 0 | 0.6 |
| Annexon: Preserving Patient Function Is The Real Investment Opportunity (NASDAQ:ANNX) - Seeking Alpha | Annexon: Preserving Patient Function Is The Real Investment Opportunity (NASDAQ:ANNX) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 27, 2026 | neutral | 0 | 0.6 |
| After buying shares at a $3.83 average, Annexon (ANNX) CEO Love Douglas holds 390,476 shares. - Stock Titan | After buying shares at a $3.83 average, Annexon (ANNX) CEO Love Douglas holds 390,476 shares. Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| More than 8 million people have an eye disease that can cause blindness. Annexon will present trial findings. - Stock Titan | More than 8 million people have an eye disease that can cause blindness. Annexon will present trial findings. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Annexon (ANNX) Stock Analysis Report | Financials & Insights - Benzinga France | Annexon (ANNX) Stock Analysis Report | Financials & Insights Benzinga France | View source ↗ | Benzinga France | Aug 26, 2026 | neutral | 0 | 0.6 |
| What Annexon (ANNX)'s Dual-Endpoint ARCHER II Update Means For Shareholders - Yahoo Finance | What Annexon (ANNX)'s Dual-Endpoint ARCHER II Update Means For Shareholders Yahoo Finance | View source ↗ | Yahoo Finance | Aug 24, 2026 | neutral | 0 | 0.6 |
| Expanded ARCHER II Trial And New Credit Facility Might Change The Case For Investing In Annexon (ANNX) - Simply Wall Street | Expanded ARCHER II Trial And New Credit Facility Might Change The Case For Investing In Annexon (ANNX) Simply Wall Street | View source ↗ | Simply Wall Street | Aug 21, 2026 | neutral | 0 | 0.6 |
| Annexon (ANNX), Why Is The Market Paying Closer Attention? - Simply Wall Street | Annexon (ANNX), Why Is The Market Paying Closer Attention? Simply Wall Street | View source ↗ | Simply Wall Street | Aug 16, 2026 | neutral | 0 | 0.6 |
| Citizens upgrades Annexon stock rating on trial endpoint changes - Investing.com | Citizens upgrades Annexon stock rating on trial endpoint changes Investing.com | View source ↗ | Investing.com | Aug 13, 2026 | neutral | 0 | 0.6 |
| Annexon Launches Long-Term Extension for Vonaprument Trial - Stock Titan | Annexon Launches Long-Term Extension for Vonaprument Trial Stock Titan | View source ↗ | Stock Titan | Aug 12, 2026 | neutral | 0 | 0.6 |
| Annexon posts $55.3 million Q2 loss and extends runway into 2028 - Quiver Quantitative | Annexon posts $55.3 million Q2 loss and extends runway into 2028 Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| ANNX Forecast — Price Target — Prediction for 2027 - TradingView | ANNX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $ANNX Buys 613,497 Shares - Quiver Quantitative | Insider Purchase: Director at $ANNX Buys 613,497 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | May 29, 2026 | neutral | 0 | 0.6 |
| Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential - Yahoo Finance | Annexon (ANNX): 7 Small Cap Stocks with the Highest Upside Potential Yahoo Finance | View source ↗ | Yahoo Finance | Apr 27, 2026 | neutral | 0 | 0.6 |
| Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High? - Zacks Investment Research | Wall Street Analysts See a 165.52% Upside in Annexon (ANNX): Can the Stock Really Move This High? Zacks Investment Research | View source ↗ | Zacks Investment Research | Apr 1, 2026 | neutral | 0 | 0.6 |
| $ANNX stock is up 10% today. Here's what we see in our data. - Quiver Quantitative | $ANNX stock is up 10% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.